CANCER IMMUNOTHERAPY (Q3133651)

From EU Knowledge Graph
Revision as of 10:22, 16 January 2022 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations)
Jump to navigation Jump to search
Project Q3133651 in Spain
Language Label Description Also known as
English
CANCER IMMUNOTHERAPY
Project Q3133651 in Spain

    Statements

    contained in NUTS
    Madrid
    0 references
    country
    Spain
    0 references
    EU contribution
    16,805.25 Euro
    0 references
    budget
    33,610.5 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    14 February 2015
    0 references
    end time
    6 February 2017
    0 references
    beneficiary name (string)
    LEADARTIS, S.L.
    0 references
    beneficiary
    Q3133650
    0 references
    programme
    Madrid - ERDF
    0 references
    coordinate location

    40°25'0.12"N, 3°42'12.89"W
    0 references
    postal code
    28079
    0 references
    summary
    INMUNOTERAPIA DEL CÁNCER MEDIANTE ANTICUERPOS MULTIMERICOS BIESPECIFICOS (Spanish)
    0 references
    IMMUNOTHERAPY OF CANCER THROUGH BISPECIFIC MULTIMERIC ANTIBODIES (English)
    0 references
    IMMUNOTHÉRAPIE CONTRE LE CANCER À L’AIDE D’ANTICORPS MULTIMÉRIQUES BIESPECIFIC (French)
    point in time
    2 December 2021
    0 references
    KREBSIMMUNTHERAPIE MIT BIESPECIFIC MULTIMERISCHEN ANTIKÖRPERN (German)
    point in time
    9 December 2021
    0 references
    KANKERIMMUNOTHERAPIE MET BIESPECIFIC MULTIMEER ANTILICHAMEN (Dutch)
    point in time
    17 December 2021
    0 references
    IMMUNOTERAPIA TUMORALE CON ANTICORPI MULTIMEDICI BIESPECIFIC (Italian)
    point in time
    16 January 2022
    0 references
    location (string)
    Madrid
    0 references

    Identifiers

    Spanish Kohesio ID
    DGEPF/01/21/002-17/13
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3133651&oldid=22874093"